JAAD Game Changer: "Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases"

J Am Acad Dermatol. 2023 Dec;89(6):1237. doi: 10.1016/j.jaad.2023.08.018. Epub 2023 Aug 16.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alopecia Areata* / drug therapy
  • Cyclopropanes / therapeutic use
  • Humans
  • Retrospective Studies

Substances

  • diphenylcyclopropenone
  • Cyclopropanes

Supplementary concepts

  • Diffuse alopecia